Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN

J Immunol. 1999 Jul 15;163(2):854-60.

Abstract

Three human IFN-alpha hybrids, HY-1 [IFN-alpha21a(1-75)/alpha2c(76-165)], HY-2 [IFN-alpha21a(1-95)/alpha2c(96-165)], and HY-3 [IFN-alpha2c(1-95)/alpha21a(96-166)], were constructed, cloned, and expressed. The hybrids had comparable specific antiviral activities on Madin-Darby bovine kidney (MDBK) cells but exhibited very different antiproliferative and binding properties on human Daudi and WISH cells and primary human lymphocytes. Our data suggest that a portion of the N-terminal region of the molecule is important for interaction with components involved in binding of IFN-alpha2b while the C-terminal portion of IFN is critical for antiproliferative activity. A domain affecting the antiproliferative activity was found within the C-terminal region from amino acid residues 75-166. The signal transduction properties of HY-2 and HY-3 were evaluated by EMSA and RNase protection assays. Both HY-2 and HY-3 induced activation of STAT1 and 2. However, HY-2 exhibited essentially no antiproliferative effects at concentrations that activated STAT1 and 2. Additionally, at concentrations where no antiproliferative activity was seen, HY-2 induced a variety of IFN-responsive genes to the same degree as HY-3. RNase protection assays also indicate that, at concentrations where no antiproliferative activity was seen for HY-2, this construct retained the ability to induce a variety of IFN-inducible genes. These data suggest that the antiproliferative response may not be solely directed by the activation of the STAT1 and STAT2 pathway in the cells tested.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antiviral Agents / pharmacology
  • Cattle
  • Cells, Cultured
  • DNA-Binding Proteins / metabolism
  • Growth Inhibitors / pharmacology
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Interferon Type I / chemistry
  • Interferon Type I / isolation & purification
  • Interferon Type I / metabolism*
  • Interferon Type I / pharmacology
  • Interferon-alpha
  • Molecular Sequence Data
  • Protein Binding / drug effects
  • Protein Binding / immunology
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / isolation & purification
  • Recombinant Fusion Proteins / metabolism*
  • Recombinant Fusion Proteins / physiology
  • Recombinant Proteins
  • STAT1 Transcription Factor
  • STAT2 Transcription Factor
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • Trans-Activators / metabolism
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / immunology
  • Tumor Cells, Cultured

Substances

  • Antiviral Agents
  • DNA-Binding Proteins
  • Growth Inhibitors
  • IFN-alpha21a(1-75), IFN-alpha2c(76-165) fusion protein
  • IFN-alpha21a(1-95), IFN-alpha2c(96-165) fusion protein
  • Interferon Type I
  • Interferon-alpha
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • STAT2 Transcription Factor
  • STAT2 protein, human
  • Trans-Activators
  • interferon alpha, HY-3

Associated data

  • GENBANK/AF085803
  • GENBANK/AF085804
  • GENBANK/AF085805